Φορτώνει......
Gene Therapy for Hemophilia: Facts and Quandaries in the 21st Century
Therapy for hemophilia has evolved in the last 40 years from plasma-based concentrates to recombinant proteins and, more recently, to non-factor therapeutics. Along this same timeline, research in adeno-associated viral (AAV) based gene therapy vectors has provided the framework for early phase clin...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Mediterr J Hematol Infect Dis |
|---|---|
| Κύριοι συγγραφείς: | , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
Università Cattolica del Sacro Cuore
2020
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7485465/ https://ncbi.nlm.nih.gov/pubmed/32952980 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4084/MJHID.2020.069 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|